ARTHROPLASTY
Combined IV-IA TXA further reduces blood loss versus IV TXA alone, but does not reduce transfusion
BMC Musculoskelet Disord. 2018 Sep 7;19(1):321. doi: 10.1186/s12891-018-2181-9Six randomized controlled trials were included in this meta-analysis, which sought to compare efficacy and safety measures between combined intravenous and topical tranexamic acid administration and intravenous tranexamic acid administration alone in total knee arthroplasty. Pooled analyses on total blood loss and maximum hemoglobin drop significantly favoured combined IV-IA TXA groups, though no significant difference in the rate of transfusion was observed. Rate of deep vein thrombosis also did not significantly differ between groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
